Gastric Adenocarcinoma — Trials

Gastric Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

448 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 137
Recruiting: 69
Ph III recruiting: 12
Growth YoY: +31.3%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 31.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (52)

clinicaltrialsPublishedShowing 51–61 of 61 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01567618	Dose-dense Biweekly Docetaxel Combined With 5-fluorouracil as First-line Treatment in Advanced Gastric Cancer(DaeMon)	completed	Phase 2	39	Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER	1	Nov 7, 2014	clinicaltrials
NCT00991952	Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach or Gastroesophageal Junction Cancer That Cannot Be Removed By Surgery	completed	Phase 2	19	National Cancer Institute (NCI)NIH